In the areas of rare disease, BBCR’s mission is to deliver cost-effective clinical plans and regulatory strategies for cell and gene therapy programs. Learn more at bbcrconsulting.com.

Cell and Gene therapy are often considered the new frontiers in the fight against devastating diseases, including rare diseases and cancers. Clinical trial outcomes remain consistently encouraging, and the next generation of Cell and Gene therapies show significant potential for many patients and families.

We can assist with strategies that move products to market faster, including:

• A cost-effective Clinical Plan that saves time and resources
• Medical Monitoring
• Ad-interim Chief Medical Monitor
• Indications Selection and Prioritization
• Trial Design and Protocol
• Study Remediation and Rescue
• Clinical research consultation for regulatory submissions and meetings
• Program Gap Analyses

Contact BBCR to get started

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

Company

This field is for validation purposes and should be left unchanged.

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

SEND